Latest Articles
"I'm not going to be the only woman in this situation" - Bournemouth Echo
"I'm not going to be the only woman in this situation" Bournemouth Echo
Published: April 21, 2025, 11 p.m.
Hailey Bieber dealing with recurring health issue that previously left her ‘nauseous’ and ‘emotional’ - Page Six
Hailey Bieber dealing with recurring health issue that previously left her ‘nauseous’ and ‘emotional’ Page Six
Published: April 21, 2025, 10:15 p.m.
Hailey Bieber shares health problem ｜ BANG Showbiz English - ノアドット株式会社
Hailey Bieber shares health problem ｜ BANG Showbiz English ノアドット株式会社
Published: April 21, 2025, 10 p.m.
Dr Agustí Garcia on Patient Eligibility for Evaluating Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer - OncLive
Dr Agustí Garcia on Patient Eligibility for Evaluating Chemoradiotherapy vs Radiotherapy Alone in Intermediate-Risk Cervical Cancer OncLive
Published: April 21, 2025, 7:21 p.m.
This Common Period Problem Might Actually Be A Dangerous Ovarian Cyst - Times Now
This Common Period Problem Might Actually Be A Dangerous Ovarian Cyst Times Now
Published: April 21, 2025, 1:30 p.m.
A Case Series: Activity of Pembro-Lenvatinib in dMMR EC Who Have Not Responded to Pembro-Mono - OncLive
A Case Series: Activity of Pembro-Lenvatinib in dMMR EC Who Have Not Responded to Pembro-Mono OncLive
Published: April 21, 2025, 1:17 p.m.
Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer - OncLive
Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer OncLive
Published: April 21, 2025, 1:17 p.m.
‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling - MSN
‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling MSN
Published: April 19, 2025, 1:26 a.m.
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer OncLive
Published: April 18, 2025, 3:54 p.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …
Published: April 18, 2025, 5:25 a.m.
Link copied to clipboard!